MEDIA CENTRE

HERE ARE OUR News & Articles



Feature Case Study: Warehousing, Packing and Logistics Project

Feature Case Study: Warehousing, Packing and Logistics Project

17/02/2021

This complex capital project, consisting of more than 225,000 square feet of total site development, was delivered in a live pharmaceutical environment, while enabling business as usual operations throughout. The utilised sustainable design and construction solutions and the exceptional collaborative efforts led to completing this time-critical project on time and within the budget, with safety performance five times safer than industry average. The new facilities incorporate technological innovations, which benefit productivity, enable collaborative ways of working and ensure the security of supply of essential medicines for global distribution. READ MORE

BES designs new Syringe Filling Line for the Sterile Production Plant

BES designs new Syringe Filling Line for the Sterile Production Plant

26/11/2020

BES recently completed a multidisciplinary design of the new primary packing facility, including full integration of a state-of-the-art sterile syringe filling line, for AstraZeneca in Macclesfield. The project comprised the fit-out of an existing fallow area within the live cancer drug manufacturing plant – a facility BES designed and constructed in 2016. By bringing production and packing capabilities under one roof, AstraZeneca will further streamline the distribution of their highly sensitive and valuable product, increasing its overall capacity...READ MORE

Mike Stigberg promoted to Principal Engineer

Mike Stigberg promoted to Principal Engineer

17/08/2020

We are thrilled to announce the promotion of Mike Stigberg to our new Principal Engineer. Mike joined the company seven years ago and has advanced through progressively more responsible positions within our design department, where he has played a key role in delivering projects to clients such as GSK, AstraZeneca Cambridge, Bespak and Bio Products Limited. We carried out a brief interview with Mike to learn more about his new role and his biggest passion outside working at BES. ...READ MORE

Cleanroom Energy Optimisation through CFD Simulation

Cleanroom Energy Optimisation through CFD Simulation

10/08/2020

With the introduction of a new ISO 14644-16 standard, it’s become even more important to ensure that the performance of your cleanroom has been fully optimised to reduce its energy consumption. The ISO document, published in June 2019, recognises that the energy usage of controlled environments is significantly higher than other commercial buildings of similar size. A considerable amount of energy is usually used by a cleanroom’s HVAC system, due to the high fan power required to achieve specific cleanrooms’ standards... READ MORE

#BESWorkingTogether

#BESWorkingTogether

06/05/2020

Now, more than ever, we are drawing upon the strength of BES’s collaborative culture to help us navigate through the current challenges. The Covid-19 pandemic presents a number of challenges on both personal and professional levels that we must learn to adapt to and cope with. We’d like to share with you some thoughts of our team members who currently work on design and construction projects, supporting our clients in healthcare and pharmaceutical markets. In brief interviews, they talk about their current projects and how they are finding themselves in this new reality. READ MORE

What's involved in creating an in-house aseptic drug preparation facility?

What's involved in creating an in-house aseptic drug preparation facility?

01/05/2020

Gavin Statham, Regional Director at BES, a specialist in the design and construction of cleanrooms, aseptic facilities and other sophisticated environments, discusses the demanding requirements for hospital aseptic facilities and how the healthcare sector can benefit from the experience of the pharmaceutical industry. High-specification, specialist facilities for the preparation of aseptically-prepared drugs need to provide a sterile environment that safeguards the purity and accuracy of the formulation. Such facilities are frequently built into pharmaceutical manufacturing environments where GMP (Good Manufacturing Practice) guidelines ensure compliance to recognised standards. READ MORE...

Supporting the sectors at the frontline of covid-19 response

Supporting the sectors at the frontline of covid-19 response

22/04/2020

At BES, we’re used to mission-critical project timelines. With so many of our projects in the pharmaceutical and healthcare sectors providing the specialist assets that form part of a wider strategy, every project is delivered to a critical path that makes sure we achieve the client’s objectives. During the COVID-19 pandemic, answering our clients’ requirements is more important than ever. We are supply chain partners for NHS Trusts who are on the frontline of caring for patients and preparing for increased demand on services. We’re also a key element in the pharmaceuticals delivery chain that will provide medical equipment and medicines during this challenging time, and are working with biotech organisations that are investing their expertise and resources to develop a vaccine. READ MORE...

Will digital transformation be the positive legacy of covid-19?

Will digital transformation be the positive legacy of covid-19?

09/04/2020

For all of us, these days of social distancing and self-isolation due to the COVID-19 pandemic are tough. Not only are we dealing with the commercial challenges of maintaining business continuity at a time when change is constant; we’re also trying to come to terms with a new definition of ‘normal’ across all aspects of life. We’re fortunate here at BES that the technology and agile working practices already embedded in the business are enabling us to work from home and continue collaborating with clients. The platforms we use to design and engineer specialist facilities are enabling our inter-disciplinary team to work together and share documents as normal to progress projects at design phase. READ MORE...

Making Cell & Gene Therapies Scalable and Commercial

Making Cell & Gene Therapies Scalable and Commercial

05/03/2020

These are exciting times in the life science sector. Advances in biotechnology mean it’s now possible to create bespoke treatments for an array of life-threatening conditions, providing tailored and rapid-action therapies that often combine faster and improved outcomes with less invasive treatment. This shift in science, from chemical formulations to cell and gene therapies using advanced biotech processes, is calling for a new generation of innovative cleanroom, laboratory and aseptic facilities. These facilities will enable scalable, commercial production of advanced preparations. READ MORE...

Culture and Communication

Culture and Communication

30/10/2019

“We have a great culture”, “we’re inclusive”, “we’re collaborative” – it seems that everyone is keen to promote a positive business culture as an indicator of their company’s success. The Oxford dictionary defines culture as “the ideas, customs, and social behaviour of a particular people or society”. Quite simply then, from a business perspective, culture starts with the people within a company and the behaviours they adopt. READ MORE...